Novartis CSEG101AIC05

Novartis CSEG101AIC05

Novartis CSEG101AIC05 app is using Sickle Cell Pain Diary – Self Report (SCPD-S)

App info


2.10.1.27
September 02, 2021
9
Android 4.4+
Everyone

Advertisement

App description


Android App Analysis and Review: Novartis CSEG101AIC05, Developed by eCOA. Listed in Medical Category. Current Version Is 2.10.1.27, Updated On 02/09/2021 . According to users reviews on Google Play: Novartis CSEG101AIC05. Achieved Over 9 Installs. Novartis CSEG101AIC05 Currently Has 1 Reviews, Average Rating 5.0 Stars

Novartis CSEG101AIC05 app is using Sickle Cell Pain Diary – Self Report (SCPD-S) to help patients self record their experiences with sickle cell pain and pain crises during the preceding 24 hours in a digital diary. These patient reported outcomes would be collected in a non-interventional clinical study, CSEG101AIC05 (SPOTLIGHT). The SCPD-S was developed in conjunction with patients, their caregivers and health care providers in accordance with the US Food and Drug Administration (FDA) patient reported outcome (PRO) guidance. It consists of 19 items or 4 items (determined by the answer to the first question), developed for use in people aged ≥ 12 years.
We are currently offering version 2.10.1.27. This is our latest, most optimized version. It is suitable for many different devices. Free download directly apk from the Google Play Store or other versions we're hosting. Moreover, you can download without registration and no login required.

We have more than 2000+ available devices for Samsung, Xiaomi, Huawei, Oppo, Vivo, Motorola, LG, Google, OnePlus, Sony, Tablet ... with so many options, it’s easy for you to choose games or software that fit your device.

It can come in handy if there are any country restrictions or any restrictions from the side of your device on the Google App Store.

What's New


New languages

Rate and review on Google Play store


5.0
1 total
5 0
4 0
3 0
2 0
1 0